Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suicide gene therapy using E. coli beta-galactosidase.

David Farquhar1, Bih Fang Pan, Mamoru Sakurai

  • 1Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. dfarquhar@mdacc.tmc.edu

Cancer Chemotherapy and Pharmacology
|July 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Statin use and Pancreatic Cancer: A Meta-analysis of its Association with Incidence in the General Population and Survival in Patients.

Journal of gastrointestinal cancer·2026
Same author

The role of jasmonic acid and methyl jasmonate in enhancing photosynthesis and stress response.

Journal of plant physiology·2026
Same author

Evolutionary shift in catalytic function of OsGLYI-10 from a glyoxalase homolog to a glutathione-s-transferase in rice.

Plant molecular biology·2025
Same author

Comprehensive analysis of proline metabolizing genes reveals their functional diversification and abiotic stress response in Solanum lycopersicum.

PloS one·2025
Same author

Computational investigation of hepatocyte growth factor receptor-ligand interactions for the identification of novel therapeutic inhibitors.

Computers in biology and medicine·2025
Same author

Exogenous salicylic acid, abscisic acid, and shikimic acid enhance drought tolerance in tea by modulating antioxidant defense and osmotic regulation.

PloS one·2025

This study explored using E. coli beta-galactosidase (beta-gal) for suicide gene therapy. While effective in vitro, the approach showed limited success in vivo due to poor drug distribution.

Area of Science:

  • Oncology
  • Gene Therapy
  • Pharmacology

Background:

  • Suicide gene therapy enhances antitumor agent selectivity via intratumoral enzyme expression.
  • Common strategies involve herpes simplex virus thymidine kinase/ganciclovir and E. coli cytosine deaminase/5-fluorocytosine.
  • Novel approaches are needed to improve targeted cancer treatment.

Purpose of the Study:

  • To investigate a novel suicide gene therapy utilizing E. coli beta-galactosidase (beta-gal) as the prodrug-activating enzyme.
  • To evaluate prodrugs activated by beta-gal for potential use against human solid tumors.
  • To leverage existing knowledge of beta-gal tumor targeting in experimental and clinical settings.

Main Methods:

  • Two anthracycline prodrugs, Daun02 and gal-DNC4, were synthesized and evaluated as substrates for beta-gal.

Related Experiment Videos

  • Cytotoxicity of Daun02 was assessed against beta-gal-transduced murine and human tumor cell lines in vitro.
  • In vivo antitumor efficacy of Daun02 was studied in a Panc02 mouse xenograft model.

    • Main Results:

    • Daun02 demonstrated good substrate activity for beta-gal, yielding daunomycin.
    • Beta-gal-transduced tumor cells showed significantly increased sensitivity to Daun02 compared to controls.
    • In vivo studies revealed no significant inhibition of tumor growth, attributed to limited prodrug distribution.

    Conclusions:

    • E. coli beta-gal shows promise as a prodrug-activating enzyme for suicide gene therapy, enhancing selective toxicity.
    • The in vitro efficacy was not replicated in vivo, highlighting challenges in drug-tissue distribution.
    • Further research is needed to optimize delivery and distribution for effective in vivo application.